Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Vinpocetina para el deterioro cognitivo y la demencia

Information

DOI:
https://doi.org/10.1002/14651858.CD003119Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 20 January 2003see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Dementia and Cognitive Improvement Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Szabolcs Szatmári

    Correspondence to: Department of Neurology, University of Medicine and Pharmacy Tg. Mures, Targu Mures, Romania

    [email protected]

  • Peter Whitehouse

    Department of Neurology, Center University Hospitals of Cleveland Room 357C, Fairhill Center, Cleveland, USA

Contributions of authors

‐SzSz: drafting of review versions, selection of trials for inclusion/exclusion; extraction of data; entry of data; interpretation of data analyses
‐PW: drafting of review versions, selection of trials for inclusion/exclusion; interpretation of data analyses.

‐Consumer editor: Suzie Sami
‐Contact editor: J. Grimley Evans
‐This review has been peer reviewed

Update search 2007: Dymphna Hermans; update search 2009: Vittoria Lutje.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • NIH/NIA Medical Goals in Dementia: Ethics and Quality of Life, USA.

  • Shigeo & Megumi Takayama Foundation, USA.

Declarations of interest

Peter Whitehouse consults for a variety of pharmaceutical companies that might be competitors for this product in the market including Janssen (galantamine), Forest Labs (memantine) and Pfizer (donepezil).

Acknowledgements

Dymphna Hermans and Vittoria Lutje, Jacqueline Birks and John Grimley Evans from the CDCIG Editorial Board for substantial help in preparing the review.
Susie Sami, consumer editor.
Péter Bönöck , Gedeon Richter Ltd., for collecting reprints and unpublished data.
Dániel Bereczki from Cochrane Stroke Group for valuable advice.

Version history

Published

Title

Stage

Authors

Version

2003 Jan 20

Vinpocetine for cognitive impairment and dementia

Review

Szabolcs Szatmári, Peter Whitehouse

https://doi.org/10.1002/14651858.CD003119

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.